Therapeutic Effect of Arctiin and Arctigenin in Immunocompetent and Immunocompromised Mice Infected with Influenza A Virus

DOI Web Site Web Site PubMed 被引用文献4件 参考文献19件 オープンアクセス
  • Hayashi Kyoko
    Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama
  • Narutaki Kazuto
    Department of Life Science and Biotechnology, Faculty of Chemistry, Materials and Engineering, Kansai University
  • Nagaoka Yasuo
    Department of Life Science and Biotechnology, Faculty of Chemistry, Materials and Engineering, Kansai University
  • Hayashi Toshimitsu
    Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama
  • Uesato Shinichi
    Department of Life Science and Biotechnology, Faculty of Chemistry, Materials and Engineering, Kansai University

この論文をさがす

説明

Arctiin and its aglucone, arctigenin from the fruits of Arctium lappa L. showed potent in vitro antiviral activities against influenza A virus (A/NWS/33, H1N1) (IFV). Based on the data from time-of-addition experiments and on release tests of progeny viruses, arctigenin was assumed to interfere with early event(s) of viral replication after viral penetration into cells, and to suppress the release of progeny viruses from the host cells. Arctiin was orally effective against either IFV-inoculated normal or 5-fluorouracil (5-FU)-treated mice, being less effective as compared with oseltamivir. Noticeably, arctiin produced a larger amount of virus-specific antibody than those of control and oseltamivir in sera collected from 5-FU-treated mice. Furthermore, oral treatment of 5-FU-treated mice with arctiin did not induce any resistant viruses, although the same treatment with oseltamivir induced resistant viruses at a 50% frequency. When the combination of arctiin and oseltamivir was administered to normal mice infected with IFV, the virus yields in both bronchoalveolar lavage fluids and lungs were significantly reduced relative to those in the mice treated with arctiin or oseltamivir alone. Thus, monotherapy of arctiin or combined therapy of arctiin with oseltamivir would be another treatment option for influenza.

収録刊行物

被引用文献 (4)*注記

もっと見る

参考文献 (19)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ